[Responsibility of the anaesthetist in preoperative risk management. Comments on the legal implications of medical publications in this field]. / Die Verantwortung des Anästhesisten in der präoperativen Risikoabklärung. Bemerkungen zu der rechtlichen Bedeutung von medizinischen Publikationen zu diesem Thema.

There is an increasing number of publications in the medical literature which address the medical and legal obligations of a specialist in a given field. These articles, mostly editorials, seek to delineate the optimal course of treatment based on the current state of the art and science of medicine. However, we believe that the unreflected adoption of these often highly theoretical ideas and suggestions carries its own dangers. For one thing, there is the threatening financial crisis in the public health system. In addition, the feasibility of implementing these suggestions in routine medical and surgical practice is questionable. Last but not least, suggestions and guidelines for preoperative risk management by, for instance, Lingnau and Strohmenger 2002 cross the well established boundaries of the various medical and surgical specialties, which obviously demands careful deliberations among the specialties involved. So far, few specialty boards have seen fit to act on these suggestions. Our article on the medical and legal responsibilities of the anaesthesiologist in perioperative risk management restates the aforementioned concerns. We attempt to point out medical and legal points of controversy. In particular, we caution against the ever present danger of a bona fide adoption of visionary guidelines as the "standard of care" by both medical and legal experts. We feel that it is imperative to carefully evaluate editorial comments and suggestions, however well meaning, in the light of established teaching and practice, lest these comments and suggestions become the basis of an unjustified determination of a physicians innocence or guilt in a court of law.

Carbon monoxide production from desflurane, enflurane, halothane, isoflurane, and sevoflurane with dry soda lime.

BACKGROUND: Previous studies in which volatile anesthetics were exposed to small amounts of dry soda lime, generally controlled at or close to ambient temperatures, have demonstrated a large carbon monoxide (CO) production from desflurane and enflurane, less from isoflurane, and none from halothane and sevoflurane. However, there is a report of increased CO hemoglobin in children who had been induced with sevoflurane that had passed through dry soda lime. Because this clinical report appears to be inconsistent with existing laboratory work, the authors investigated CO production from volatile anesthetics more realistically simulating conditions in clinical absorbers. METHODS: Each agent, 2.5 or 5% in 2 l/min oxygen, were passed for 2 h through a Dräger absorber canister (bottom to top) filled with dried soda lime (Drägersorb 800). CO concentrations were continuously measured at the absorber outlet. CO production was calculated. Experiments were performed in ambient air (19-20 degrees C). The absorbent temperature was not controlled. RESULTS: Carbon monoxide production peaked initially and was highest with desflurane (507 +/- 70, 656 +/- 59 ml CO), followed by enflurane (460 +/- 41, 475 +/- 99 ml CO), isoflurane (176 +/- 2.8, 227 +/- 21 ml CO), sevoflurane (34 +/- 1, 104 +/- 4 ml CO), and halothane (22 +/- 3, 20 +/- 1 ml CO) (mean +/- SD at 2.5 and 5%, respectively). CONCLUSIONS: The absorbent temperature increased with all anesthetics but was highest for sevoflurane. The reported magnitude of CO formation from desflurane, enflurane, and isoflurane was confirmed. In contrast, a smaller but significant CO formation from sevoflurane was found, which may account for the CO hemoglobin concentrations reported in infants. With all agents, CO formation appears to be self-limited.

Absorbents differ enormously in their capacity to produce compound A and carbon monoxide.

UNLABELLED: Concern persists regarding the production of carbon monoxide (CO) and Compound A from the action of carbon dioxide (CO(2)) absorbents on desflurane and sevoflurane, respectively. We tested the capacity of eight different absorbents with various base compositions to produce CO and Compound A. We delivered desflurane through desiccated absorbents, and sevoflurane through desiccated and moist absorbents, then measured the resulting concentrations of CO from the former and Compound A from the latter. We also tested the CO(2) absorbing capacity of each absorbent by using a model anesthetic system. We found that the presence of potassium hydroxide (KOH) and sodium hydroxide (NaOH) increased the production of CO from calcium hydroxide (Ca[OH](2)) but did not consistently affect production of Compound A. However, the effect of KOH versus NaOH was not consistent in its impact on CO production. Furthermore, the effect of KOH versus NaOH versus Ca(OH)(2) was inconsistent in its impact on Compound A production. Two absorbents (Amsorb) [Armstrong Medica, Ltd, Coleraine, Northern Ireland], composed of Ca(OH)(2) plus 0.7% polyvinylpyrrolidine, calcium chloride, and calcium sulfate; and lithium hydroxide) produced dramatically lower concentrations of both CO and Compound A. Both produced minimal to no CO and only small concentrations of Compound A. The presence of polyvinylpyrrolidine, calcium chloride, and calcium sulfate in Amsorb appears to have suppressed the production of toxic products. All absorbents had an adequate CO(2) absorbing capacity greatest with lithium hydroxide. IMPLICATIONS: Production of the toxic substances, carbon monoxide and Compound A, from anesthetic degradation by carbon dioxide absorbents, might be minimized by the use of one of two specific absorbents, Amsorb (Armstrong Medica, Ltd., Coleraine, Northern Ireland) (calcium hydroxide which also includes 0.7% polyvinylpyrrolidine, calcium chloride, and calcium sulfate) or lithium hydroxide.

[The use of lithium hydroxide for carbon dioxide absorption prevents formation of compound A during sevoflurane anesthesia]. / Die Anwendung von Lithiumhydroxid als Kohlendioxidabsorbens verhindert das Entstehen von Compound A während Sevoflurananästhesie.

UNLABELLED: Aim of the study was the clinical investigation of sevoflurane degradation when using water-free lithiumhydroxide versus moist Drägersorb 800 for carbon dioxide absorption. METHODS: Concentrations of Compound A in the inspiratory gas mix and serum fluoride levels were measured in two groups of 8 patients each. RESULTS: When water-free lithiumhydroxide was used for carbon dioxide absorption, concentration of Compound A in the inspiratory gas mix was ca. 1 ppm (near minimal level of detection) as compared to ca. 20 ppm for moist Drägersorb 800. The concentration of fluoride increased during sevoflurane anesthesia (15.0 +/- 4.8 mumol/l with lithiumhydroxide versus 21.9 +/- 4.0 mumol/l with Drägersorb 800 after 60 mins). CONCLUSIONS: When lithiumhydroxide is used, there is only minimal formation of compound A from sevoflurane degradation. Since serum fluoride levels increased in both patient groups, we conclude that this is caused mainly by metabolism of sevoflurane. Capacity of lithiumhydroxide for carbon dioxide absorption is similar to that of Drägersorb 800. Therefore, the use of lithiumhydroxide increases patient safety.

The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption.

UNLABELLED: Normal (hydrated) soda lime absorbent (approximately 95% calcium hydroxide [Ca(OH)2], the remaining 5% consisting of a mixture of sodium hydroxide [NaOH] and potassium hydroxide [KOH]) degrades sevoflurane to the nephrotoxin Compound A, and desiccated soda lime degrades desflurane, enflurane, and isoflurane to carbon monoxide (CO). We examined whether the bases in soda lime differed in their capacities to contribute to the production of these toxic substances by degradation of the inhaled anesthetics. Our results indicate that NaOH and KOH are the primary determinants of degradation of desflurane to CO and modestly augment production of Compound A from sevoflurane. Elimination of these bases decreases CO production 10-fold and decreases average inspired Compound A by up to 41%. These salutary effects can be achieved with only slight decreases in the capacity of the remaining Ca(OH)2 to absorb carbon dioxide. IMPLICATIONS: The soda lime bases used to absorb carbon dioxide from anesthetic circuits can degrade inhaled anesthetics to compounds such as carbon monoxide and the nephrotoxin, Compound A. Elimination of the bases sodium hydroxide and potassium hydroxide decreases production of these noxious compounds without materially decreasing the capacity of the remaining base, Ca(OH)2, to absorb carbon dioxide.

Carbon dioxide absorption: toxicity from sevoflurane and desflurane.

The degradation of volatile anaesthetics by desiccated carbon dioxide absorbents can result in adverse outcomes. Desiccated carbon dioxide absorbent reacting with desflurane can cause potentially life-threatening intraoperative carbon monoxide exposure; the reaction with sevoflurane can cause the formation of several toxic breakdown products, e.g. compound A. Compound A-related renal toxicity in humans is still a matter of controversy.

[Uptake and distribution of sevoflurane]. / Aufnahme und Verteilung von Sevofluran.

Sevoflurane is characterized by a low blood/gas partition coefficient of 0.69, only desflurane and nitrous oxide have lower blood/gas solubilities. Alveolar equilibration is fast, a feature useful for rapid induction of anesthesia. Because of its pleasant smell, mask induction is feasible and routinely used in clinical settings. Formation of inorganic fluoride by metabolism and by compound A by degradation in CO2-absorbent has not yet been shown to be nephrotoxic in humans. Pulmonal elimination of sevoflurane is rapid because of its low blood solubility. Clinical results showed that rapidity of recovery from sevoflurane anesthesia is equal to that of desflurane anesthesia. Physicochemical properties of sevoflurane allow its application in conventional vaporizers.

[The i-STAT analyzer. A new, hand-held device for the bedside determination of hematocrit, blood gases, and electrolytes]. / Der i-STAT Analyzer. Ein neues, tragbares Gerät zur Bedsidebestimmung des Hämatokrits, der Blutgase und Elektrolyte.

UNLABELLED: Exact and quick measurements of basic laboratory parameters are important in selected patients in the perioperative period. Depending on the capabilities of a hospital's central laboratory, the anaesthesiologist may only obtain such laboratory tests after unacceptable delays. This problem may be overcome by a new bedside measurement device that has become available from i-STAT Corporation, Princeton, USA. The hand-held, battery-driven analyser accepts blood specimens that are injected into a disposable cartridge (EG7+) and measures acidity, blood gas tensions, haematocrit, and electrolytes. The aim of this study was to determine the accuracy of such measurements by comparing them with measurements obtained by conventional laboratory test methods. METHODS: Heparinised arterial blood specimens were collected in duplicate from 49 surgical patients. Measurements of ionised calcium (Ca), sodium (Na), potassium (K), pH, pCO2, pO2, base excess (BE), haematocrit (Hct), and haemoglobin (Hb) obtained by the i-STAT analyser were compared with measurements from the calibrated analysers ABL 615 and EML 100 (Radiometer, Copenhagen). Because the i-STAT analyser calculates the Hb concentration from a conductometrically measured Hct, 19 blood specimens were centrifuged in order to compare test results with conventionally obtained Hct and Hb values. As the Hct test sensitivity with the i-STAT changes with diluted blood due to its low albumin concentration, Hct and Hb measurements during cardio-pulmonary bypass (CPB) must be corrected by activating an analyser-implemented correction algorithm (Hct/CPB and Hb/CPB). Correlation analysis was performed between conventional measurements and i-STAT values (Ca, Na, K, Hct, pCO2, pO2), between values that the i-STAT analyser derives (Hb, HCO3, BE) and conventionally obtained results, and between normal and CPB-corrected Hct and Hb values. Accuracy was judged according to the national quality standard, which requires test results to lie within the 95% confidence interval of conventional tests. RESULTS: Each blood specimen was analysed: erroneous results or technical failures did not occur. Measurement of one set of i-STAT values required 2.5 min. Correlation coefficients (r) between conventional and i-STAT results were: 0.85 for CA, 1.0 for K; 0.86 for Na; 0.99 for pH; 0.98 for pCO2; 0.99 for pO2; 0.93 for HCO3; 0.93 for BE; 0.46 for Hb values not corrected for CPB and 0.95 for CPB-corrected Hb; and 0.74 for Hct values not corrected for CPB and 0.98 for CPB-corrected Hct. The correlation coefficient for Hct between centrifuged and CPB-uncorrected i-STAT values was 0.81 and that for CPB-corrected values was 0.98. National accuracy requirements were not met for tests of: Ca (by 0.02 mmol/l); pH (by 0.01); pO2 including hyperoxic values (by 26.7 mmHg, but were met for pO2 values < 200 mmHg); Hb (by 1.6 g/dl); Hb/CPB (by 0.8 g/dl); and Hct (by 6.5%, but were met for Hct/CPB values). All other tests fulfilled the required standards. CONCLUSION: This analyser is easy to use, reliable, and portable, and therefore suitable for the operating room, for analyses during emergencies, on peripheral wards, for preclinical screening, or at times when availability of lab tests is time-consuming or limited. The test accuracy for electrolytes, blood gases, and Hb is high enough to justify routine use of the i-STAT analyser in clinical practice. That the nationally required quality standards for Ca, pH, and Hb were not met is not of importance because the measured deviation was too small to have clinical relevance. When analysing diluted blood with a low Hct and low oncotic pressure, it is important to activate the analyser's correction algorithm "CPB", because the obtained results will then comply with the required accuracy.

[Interactions of dry soda lime with enflurane and sevoflurane. Clinical report on two unusual anesthesias]. / Interaktion von trockenem Atemkalk mit Enfluran und Sevofluran. Klinischer Bericht über zwei ungewöhnliche Anästhesieverläufe.

UNLABELLED: We report two cases of unexpected courses of inhalation anaesthesia with sevoflurane and enflurane which were caused by the presence dry soda lime. Case 1: During mask induction of a healthy 46-year-old female patient for elective hysterectomy it was noted that the vaporizer setting of 5% sevoflurane (in 50% O2, 50% N2O) did not result in the expected increase of inspiratory sevoflurane concentration. At the same time, the anaesthesiologist observed that the patient did not lose consciousness while the temperature of the soda lime canister increased sharply and the colour of the soda lime turned to blue with condensing water visible in the tubing. It was later determined that this anaesthesia machine had not been used for more than 2 weeks. Analysis of the soda lime showed a water content of <1%. Case 2: Following intravenous induction of a non-smoking 64-year-old male patient for elective gastrectomy, it was noted that the concomitant inhalation of enflurane was associated with a sharp rise in the temperature of the soda lime canister, a colour change of the soda lime to blue and a decrease in the measured inspiratory enflurane concentration despite an unchanged or even increased vaporizer setting. Arterial blood gas analysis revealed a CO-Hb concentration of 8.8% with otherwise normal acidity and partial gas pressures. Immediate change of the absorbant resulted in a decline in the CO-Hb concentration to 6.9% within 3 h. It was later determined that the anaesthesia machine had not been used for 34 h. Analysis of the soda lime showed a water content of 5.4%. DISCUSSION: Both case reports were associated with a rise in temperature and a colour change to blue of the soda lime. Reactions of desflurane, enflurane or isoflurane with dry soda lime resulting in significant CO-Hb formation have been previously reported. Reactions of sevoflurane with dry soda lime have been observed but have so far not been published. Until further analysis of these phenomena is completed, it is mandatory for the patient's safety to guarantee that only soda lime with a sufficient water content be used for clinical anaesthesia.

[Heat production from reaction of inhalation anesthetics with dry soda lime]. / Zur Temperaturentwicklung von Inhalationsanästhetika auf trockenem Atemkalk.

UNLABELLED: There are some case reports about excessive heat production in the absorbent canister when sevoflurane or enflurane are washed into a circle containing dried soda lime. This observation was often made in the DRAGER ISO 8 circle system with the gas inlet upstream of the soda lime canister with the gas-flow from bottom to top. METHODS: The temperature in the center of an absorbent canister was measured 3.0 cm and 7.5 cm above the bottom. Soda lime (DRAGERSORB 800) was dried in an O2 stream for 2-3 days until there was no further loss in weight. 5 Vol% of desflurane, enflurane, isoflurane and sevoflurane in 2 1/min O2 or 4 Vol% of halothane in 2.5 I/min O2 were continuously fed into the canister. The concentration of the respective inhalational agents were measured after the soda lime canister using a DATEX Capnomac. Experiments were performed at ambient temperatures of 20-22 degrees C. RESULTS: A considerable temperature increase was achieved with all anaesthetics. The highest temperatures were measured at the upper sensor with 56-58 degrees C for desflurane, 76-80 degrees C for enflurane and isoflurane, 84-88 degrees C for halothane and 126-130 degrees C for sevoflurane. IR-detection for some agents was considerably delayed or the time course indicated that other compounds might have formed which absorb at the wavelength monitored. DISCUSSION: The high temperatures indicate the degradation rather than absorption of the volatile anaesthetics. CO is known to be degradation product of all currently used volatile anaesthetics except sevoflurane. Sevoflurane, however, produced the highest temperatures passing through dried soda lime. There are no reports about new specific breakdown products for sevoflurane on dried soda lime.

[Causes for the reaction between dry soda lime and halogenated inhalation anesthetics]. / Uber die Ursachen der Reaktion zwischen trockenem Atemkalk und halogenierten Inhalationsanästhetika.

All volatile anesthetics undergo chemical breakdown to multiple, partly identified degradation products in the presence of dry soda lime. These chemical reactions are highly exothermic, ranging from 100 degrees C for halothane to 120 degrees C for sevoflurane. The increase in temperature correlates with the moisture content of the soda lime, being maximal below 5%. Sevoflurane and isoflurane were exposed to dry soda lime in a circle system. The anaesthetic gas was condensed in a series of cold temperature traps and the degradation products of the volatile anesthetics were analysed using GC/MS. Surprisingly, neither sevoflurane nor its degradation products could be measured in the gas-flow emerging from the soda lime during the first 15-20 min of exposure. After 20 minutes, larger quantities of methanol, compounds C and D as well as compounds A and B were detected. After 40-60 min of exposure, sevoflurane's degradation markedly decreased and unaltered sevoflurane emerged from the soda lime canister. Additionally, using isoflurane in the same experimental set-up resulted in various degradation products due to its reaction with dry soda lime. Obviously, all volatile anesthetics are prone to such a reaction. In conclusion, sevoflurane and isoflurane react with dry soda lime. These reactions are caused by the presence of two components of soda lime, sodium hydroxide and potassium hydroxide. A modification of soda lime to prevent its reaction with volatile anaesthetics is discussed.

[Uptaken distribution and metabolism of sevoflurane]. / Aufnahme, Verteilung und Metabolismus von Sevofluran.

The inhalational anaesthetic fluor-methyl-trifluor-1-(trifluoromethyl)-ethylether sevoflurane has been known for more than 20 years and is structurally related to the currently available volatile anaesthetics. This anaesthetic is characterized by a low blood/gas partition coefficient of 0.69 and high fat solubility, leading to a sharp rise in alveolar concentration and quick anaesthesia induction. As opposed to desflurane, sevoflurane does not boil at ambient temperature, thus making a special vaporizer unnecessary. The alveolar uptake of sevoflurane is 20% and 66% faster than that of isoflurane and halothane respectively. Elimination of sevoflurane from the blood is twice as quick as that of halothane; the younger the patient, the earlier awakening from anaesthesia occurs. When administered in oxygen the minimal anaesthetic concentration (MAC) of sevoflurane in adults is 1.71 vol%; when administered in 60% nitric oxide, the MAC decreases to 0.66 vol%. The variations of published MAC determinations seem to results from geographical or population-specific potency differences of sevoflurane. In children MAC varies between 2.03 and 2.49 vol%. Biodegredation of sevoflurane occurs immediately following inhalation, leading to separation of ionized and of organically bound fluoride. As opposed to methoxyflurane, which may be nephrotoxic due to its microsomal metabolism in kidney tissue, sevoflurane does not seem to cause clinical inhibition of renal function even at plasma fluoride levels above 50 mumol/l, a concentration thought to be associated with renal tubular impairment. A possible reason for this observation is lower metabolism of sevoflurane within renal tissues. Due to its quick onset and fast elimination, sevoflurane is an interesting new volatile anaesthetic offering various clinical advantages.